Ellen Go, MD, Pediatric Rheumatologist, Riley Hospital for Children, Indianapolis, Indiana
2022 Vasculitis Pediatric Conference: Medications–What’s available for childhood vasculitis?

Introduction Dr. Ellen Go | 0:20 |
Drug discovery and development is a long and risky road. | 2:48 |
Facts about pediatric research. | 6:53 |
Programs to support pediatric drug development. | 7:54 |
Treatment considerations in childhood systemic vasculitis. | 8:45 |
What do these drugs have in common? | 10:02 |
Cyclophosphamide (low dose) | 10:57 |
Rituximab | 12:58 |
Steroids | 14:15 |
Methotrexate | 16:00 |
Azathioprine | 17:28 |
Tocilizumab | 18:36 |
Infliximab | 19:24 |
Mepolizumab | 21:02 |
Avocopan | 21:52 |
Takeaway tips. | 22:52 |
Ellen Go, MD, Pediatric Rheumatologist, Riley Hospital for Children, Indianapolis, Indiana
The VF is the leading organization
in the world dedicated to diagnosing, treating, and curing all forms
of vasculitis.
The Vasculitis Foundation is a registered 501(c)(3) nonprofit organization. All contributions are 100% tax-deductible.
Click here to send us an email!
Mail:
Vasculitis Foundation
PO Box 28660
Kansas City, MO 64188
1.816.436.8211 or 1.800.277.9474
Fax: 1.816.656.3838
All Rights Reserved